v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net loss $ (24,452) $ (15,435)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 235 123
Amortization of licensed right to use technology 102 19
Stock-based compensation 9,338 2,371
Amortization of debt discount and accretion of debt issuance costs 67
Amortization of operating lease assets 138 97
Unrealized loss on marketable securities (5)
Foreign currency adjustments 394 9
Write-off of assets no longer used 235
Provision for inventory losses 49
Changes in:    
Grant receivable 87 425
Inventory (363)
Other current assets and prepaid expenses 421 (20)
Accounts payable 864 900
Accrued expenses (3,108) 2,551
Net cash used in operating activities (16,059) (8,898)
Cash flows from investing activities    
Purchase of marketable securities (32,617)
Security deposits made on operating leases 2 (73)
Purchase of property and equipment (1,221) (619)
Net cash used in investing activities (33,835) (692)
Cash flows from financing activities    
Proceeds from issuance of common stock in connection with a Purchase agreement 1,031
Proceeds from issuance of common stock through at the Market offerings 214 22,440
Proceeds from issuance of common stock through exercise of stock options 50
Payment of loan (617) (453)
Net cash (used in) / provided by financing activities (403) 23,068
Effect of exchange rate changes on cash and cash equivalents 2
Increase (decrease) in cash, cash equivalents and restricted cash (50,296) 13,478
Cash, cash equivalents and restricted cash at beginning of period 90,230 35,268
Cash, cash equivalents and restricted cash at end of period 39,934 48,746
Supplemental disclosure of non-cash investing and financing activities    
Right-of-use assets 274
Operating lease liability 274
Supplemental disclosure of cash flow items:    
Interest paid 16 179
Income taxes paid $ 64